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Abstract
Aims/hypothesis Candidate gene and genome-wide associa-
tion studies have identified ∼60 susceptibility loci for type 2
diabetes. A majority of these loci have been discovered and
tested only in European populations. The aim of this study
was to assess the presence and extent of trans-ethnic effects of
these loci in an East Asian population.
Methods A total of 9,335 unrelated Chinese Han individuals,
including 4,535 with type 2 diabetes and 4,800 non-diabetic
ethnically matched controls, were genotyped using the
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Illumina 200K Metabochip. We tested 50 established loci for
type 2 diabetes and related traits (fasting glucose, fasting
insulin, 2 h glucose). Disease association with the additive
model of inheritance was analysed with logistic regression.
Results We found that 14 loci significantly transferred to the
Chinese population, with two loci (p =5.7×10−12 forKCNQ1 ;
p =5.0×10−8 forCDKN2A/B-CDKN2BAS) reaching indepen-
dent genome-wide statistical significance. Five of these 14
loci had similar lead single-nucleotide polymorphisms (SNPs)
as were found in the European studies while the other nine
were different. Further stepwise conditional analysis identified
a total of seven secondary signals and an independent novel
locus at the 3′ end of CDKAL1 .
Conclusions/interpretation These results suggest that many
loci associated with type 2 diabetes are commonly shared
between European and Chinese populations. Identification
of population-specific SNPs may increase our understanding
of the genetic architecture underlying type 2 diabetes in
different ethnic populations.
Keywords Ethnic difference . Genetic association .
Type 2 diabetes
Abbreviations
CHB+CHD Chinese in Beijing + Chinese in Denver
CSMC Cedars-Sinai Medical Center
eQTL Expression quantitative trait locus
eSNPs Expression SNPs
GWAS Genome-wide association studies
LD Linkage disequilibrium
MAF Minor allele frequency
PC Principal component




Type 2 diabetes and its associated complications pose a major
global healthcare burden. It is estimated that 552 million
people worldwide will be affected by diabetes by the year
2030 and a majority of the affected will be Asians [1, 2]. Due
to an exponential population growth, ageing population and
increased rate of urbanisation, there is a rapidly emerging
diabetes epidemic in Asia [3]. Exploring the underlying ge-
netic architecture of type 2 diabetes in Asian populations may
improve our understanding of the pathogenesis of this devas-
tating disease and aid in the development of novel, effective
and safe therapeutic alternatives to reduce its risk.
Candidate gene and genome-wide association studies
(GWAS) have identified ∼60 loci associated with type 2
diabetes and related traits (fasting glucose, fasting insulin
and 2 h glucose), but a majority of the heritability remains
unexplained [4]. Most of these loci were initially identified
from studies of European ancestry, with the exception of
KCNQ1 , UBE2E2 , C2CD4A/B , PTPRD , SRR , SPRY2 ,
PEPD , KCNK16 , MAEA , GCC1-PAX4 , PSMD6 and
ZFAND3 , which were first discovered in East Asian groups
[5–8]. The transferability of the risk variants of type 2 diabetes
genes across different populations has not been consistently
observed. In some cases, this discrepancy may reflect sub-
stantial differences in the affect allele frequency between race/
ethnic groups. For example, in an earlier study of TCF7L2 ,
the strongest risk variant associated with type 2 diabetes in
multiple European populations was found in the T allele of
rs7903146 at the 5′ end of the gene [9]. However, the
frequency of the T allele of rs7903146 in Asian individuals
was rather rare (minor allele frequency 2–2.5%). Instead,
rs290487, located in a linkage disequilibrium (LD) block at
the 3′ end of the gene, was associated with type 2 diabetes in
Chinese individuals, suggesting a distinct genetic variation of
TCF7L2 in East Asians compared with that in Europeans
[10]. Similarly, in another study examining the transferability
of type 2 diabetes loci from European studies in 10,718
individuals of Chinese, Malay and East Asian Indian ethnic-
ities, there was evidence of a population-specific effect, allelic
heterogeneity and LD variations atCDKAL1 andHHEX/IDE/
KIF11 loci in all three cohorts [11].
Recent studies suggest that there is a phenotypic distinction
in the clinical presentation of type 2 diabetes between East
Asians and Europeans [1, 3, 12, 13], hence the importance of
delineating the specific susceptibilities in each group. Thus,
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examining population-specific signals may help to detect the
underlying causal variant(s) that affect(s) different populations
and may provide insights into the functional biology that may
differ among different ethnic groups [14].
Fine mapping through dense genotyping of a locus of
interest represents one approach for detecting population-
specific variants. This approach has been successfully applied
on a locus-by-locus basis for different diseases (e.g. SORT1 at
the 1p13 locus for myocardial infarction and LDL-cholesterol
[15] or ZNF365D in Crohn’s disease [16]). TheMetabochipwas
developed to fine-map multiple metabolic and cardiovascular-
related loci simultaneously in a cost-effective manner [17].
Approximately 43,292 of the 196,725 single-nucleotide
polymorphisms (SNPs) on the Metabochip, including many
less-common and rare variants from the 1,000 Genome Project,
were selected to fine-map the previously identified type 2
diabetes and related-trait loci.
Here we report the association results for these fine-
mapping SNPs on the Metabochip in a case–control study of
4,535 unrelated Chinese individuals with type 2 diabetes and
4,800 non-diabetic controls.
Methods
Ethics statement This study was performed in accordance
with the tenets of the Declaration of Helsinki and approved
by the Institutional Review Boards of each participating centre
in the USA and Taiwan. Informed consent was obtained from
the study participants.
Cohorts The TaiChi consortium was formed through a col-
laborative effort between investigators based in the USA and
Taiwan. The consortium’s primary aim is to identify genetic
determinants of atherosclerosis- and diabetes-related traits in
East Asians and to fine-map validated loci identified in other
race/ethnic groups.
The main academic sites participating in the TaiChi consor-
tium in Taiwan include Taichung Veteran’s General Hospitals,
Taipei Veterans General Hospital, National Health Research
Institutes, Tri-Service General Hospital and National Taiwan
University Hospital. The main US academic sites include
Stanford University School of Medicine in Stanford, CA,
Hudson-Alpha Biotechnology Institute in Huntsville, AL,
Cedars-Sinai Medical Center (CSMC) in Los Angeles, CA
and Harbor-UCLA Medical Center in Torrance, CA. TaiChi
brings together seven principal cohorts formed in Taiwan,
producing a bio-resource that includes a total of 11,859 indi-
viduals. Each cohort is described inmore detail in the electronic
supplementary material (ESM) text.
Diagnosis of type 2 diabetes and related traits A total of
9,335 unrelated individuals, comprising 4,535 patients with
type 2 diabetes and 4,800 non-diabetic ethnically matched
controls, were included in this study. The diagnosis of diabetes
was based on a fasting blood glucose level ≥6.99 mmol/l
(126 mg/dl), a positive diabetes history or the use of diabetic
medications.
Data for vital signs, fasting glucose, HbA1c and creatinine
were measured in all participants as part of routine clin-
ical and laboratory panels. Plasma glucose was measured
by the glucose oxidase–peroxidase method (WakoDiagnostics,
Tokyo, Japan).
Genotyping and quality control Blood samples were obtained
from participants and DNA samples were extracted from
buffy coats using the QIAamp DNA mini Kit (Qiagen, Valen-
cia, CA, USA). Genotyping with the Metabochip [17] was
performed at the Hudson-Alpha Biotechnology Institute in
Huntsville, AL, USA and at the Medical Genetics Institute
and the Clinical and Translational Science Institute of CSMC.
Infinium technology [18] was used for genotyping partici-
pants on the 200K Metabochip, following the manufacturer’s
protocol (Illumina, San Diego, CA, USA). Genotypes were
automatically called by GenCall, a clustering algorithm, in
Genome Studio as an initial screen, and data from the two
genotyping centres were combined before a trained specialist
at CSMC manually reviewed the cluster plots.
SNPs with a missingness >2%, minor allele frequency
(MAF) <1%, departure from the Hardy–Weinberg equilibrium
(p <10−7), located on the sex chromosomes or which were
monomorphic were removed (ESM Table 1). While a total of
93,235 SNPs passed quality control (QC) measures, only
those related to the 50 type 2 diabetes and related-trait loci
on the Metabochip were analysed (n =18,638, n =9,055 after
LD pruning).
Cryptic relatedness was defined at PI-HAT (PI) >0.12.
Where there were family members in the cohorts, a majority
of the related family members were first and second degree
relatives. In these cases, only one individual from each family
is represented in the current study.
Principal component analysis (PCA) using EIGENSTRAT
was conducted to evaluate for potential population stratifica-
tion among study participants and also to map the participants
with the population panels from the International HapMap 3
dataset [19]. Any participants who did not cluster together
with HapMap Chinese samples were excluded for further
association analyses. Ten Eigenvalues were generated and
participants greater than 10 SD from any component were
also excluded from the analysis.
In total, participants with a missingness >2%, excessive
heterozygosity, cryptic relatedness (n =1,324), sex mismatch
(n =151), missing identity numbers (n =460), ambiguous
diabetes status (n =390) or population outliers (n =199) as
defined by PCA were removed, leaving 9,335 participants
for analysis.
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Statistical analysis Disease association with the additive
model of inheritance was analysed with logistic regression.
Sex chromosomes and mitochondrial DNA were excluded
from the analysis. Age, sex and the first principal component
(PC) from PCAwere included as covariates in all analyses.
Of the ∼60 loci associated with type 2 diabetes that have
been discovered mainly from studies of European ancestries,
∼50 loci are represented on the Metabochip (ESM Table 2).
Thus, statistical significance for confirmation in TaiChi was
defined at p <10−3 after locus-specific Bonferroni correction
(p= 0.05/50=1×10−3). Only those loci achieving this level of
significance were evaluated further in this study. Results for
the additional loci achieving a nominal level of significance of
p <0.05 (24 loci) are summarised in ESM Table 2.
A more stringent statistical analysis for association was
also performed for all unlinked markers (n =9,055), resulting
in a Bonferroni correction of 5.5×10−6 (=0.05/9,055). All
analyses were carried out using PLINK [20]. Regional asso-
ciation plots of the top SNPs were generated using
LocusZoom [21] and the calculation of r2 between SNPs
was generated using SNAP [22]. Haplotype blocks and LD
structure were generated using Haploview [23]. The expres-
sion quantitative trait loci (eQTL) browser at the University of
Chicago [24] was used for correlation comparison of the
expression SNPs (eSNPs) at the CDKAL1 locus in the present
study. Direction of effect, minor allele, MAF and OR were
also compared between top European and Asian SNPs.
Conditional analysis Conditional analysis, in which SNPs
were added as additional covariates in the regression model,
were performed in two ways to indicate signals that were
either replication signals or additional secondary signals. First,
we ran the conditional analysis by conditioning on the previ-
ously reported European SNP. If the result was no longer
significant, this SNP was a replication signal. If the result
was significant, this SNP was a secondary signal. Second,
we also ran the conditional analysis by conditioning on the top
SNP in our sample. This approach was used to determine
additional secondary signals and was performed by adding
SNPs one at a time until no significance was seen. Consistent
with the locus-specific Bonferroni model, statistical signifi-
cance for the conditional analysis was defined at p <0.05,
which followed the αs used in an earlier trans-ethnic study
of type 2 diabetes mellitus [11].
Results
Demographics A total of 9,335 individuals, constituting
4,535 with type 2 diabetes (cases) and 4,800 non-diabetic
ethnically matched controls, remained for analysis after sam-
ple QC. The demographics of this cohort are summarised in
Table 1. Cases and controls were well matched for age and
sex. The cases exhibited a higher BMI (25.2 kg/m2 vs
24.7 kg/m2), a worse HbA1c (8.9% vs 5.9% [74 vs
41 mmol/mol]) and a higher fasting plasma glucose level
(9.4 vs 5.56 mmol/l) compared with the controls, consistent
with the clinical criteria and risk factors for type 2 diabetes
(Table 1).
Quality control A total of 18,638 fine-mapping SNPs (those
related to type 2 diabetes and related traits) passed QC mea-
sures and were used for association testing. For data QC
purposes, the quantile–quantile plot was generated with all
93,235 SNPs that passed QC (genomic inflation factor = 1.14)
and LD pruned (genomic inflation factor = 1.04) (ESM
Fig. 1a). The PCA plot after ancestry exclusions indicates that
individuals from the TaiChi cohort clustered together with the
HapMap CHB+CHD (Chinese in Beijing + Chinese in
Denver) populations (ESM Fig. 1b).
Type 2 diabetes and related-trait loci with known lead
SNPs Of the ∼50 type 2 diabetes and related-trait loci repre-
sented on the Metabochip, 14 loci significantly transferred to
the Chinese individuals after locus Bonferroni correction
(ESM Table 2), with the lowest p values observed for the lead
SNPs in KCNQ1 (rs2237897, p= 5.7×10−12) and CDKN2A/
B-CDKN2BAS (rs10811661, p= 5.0×10−8), respectively
(Table 2). Another 24 loci achieved a nominal significance
at p <0.05 (ESMTable 2); thus, 76% (38/50) of loci associated
with type 2 diabetes and related traits appear to be commonly
shared between the European and Chinese populations. In
addition, if one examines the direction of effect, 35 of the
available 41 loci with proxies (85.4%) significantly shared the
association in the same direction as in the Europeans (p =1.8×
10−6, ESM Tables 2 and 3). However, 12 loci were not
observed in the Chinese population even at the nominal
p value. These were NOTCH2 , SLC2A2 , WFS1 , GCK ,
HNF1A , MTNR1B , HMGA2 , KLF14 , TP53INP1 ,
CHCHD9 /TLE4 , SREBF1 and ZFAND6 , of which 9/9 (with
Table 1 Demographics of TaiChi type 2 diabetes cohort
Characteristic Controls Cases p value
n 4,800 4,535
Age (years) 65.3±0.2 64.9±0.2 NS
Sex (% female) 37.8 39.1 NS
BMI (kg/m2) 24.7±0.1 25.2±0.1 <0.0001
HbA1c (%) 5.9±0.04 8.9±0.04 <0.0001
HbA1c (mmol/mol) 41 74 <0.0001
FPG (mmol/l) 5.56±0.08 9.4±0.07 <0.0001
Values for continuous variables denote mean ± SEM
FPG, fasting plasma glucose
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available proxies, 100%) shared the association in the same
direction as in the European populations (ESMTables 2 and 3;
three were not available for evaluation due to no proxies). Of
the 14 loci that met the locus-specific Bonferroni correction,
the lead SNP of each locus was a common variant (MAF
≥5%), and each demonstrated a small effect on the association
(Table 2). We performed a more stringent statistical analysis
for association by LD pruning of type 2 diabetes loci and
found that five loci remained statistically significant after
Bonferroni correction for unlinked markers (p <5.5×10−6;
Table 2). Of those five loci, only one locus had a putative
novel SNP in our East Asian population. These data suggest
that the loci with the strongest signals are those that are present
in the European population and are trans-ethnically shared
with the East Asians.
Further examination of these 14 loci revealed that for five
(rs2237897, KCNQ1 ; rs10811661, CDKN2A/B-CDKN2BAS ;
rs11257655, CDC123/CAMK1D ; rs6769511, IGF2BP2 ;
rs1260326, GCKR), the lead SNPs are the same lead SNPs
observed in the European populations (Table 2). The regional
association plots of these loci show robust signals in these
regions (ESM Fig. 2). In evaluating the transferability of the
same lead SNPs, we found the SNP effects were in the same
direction for all five SNPs. The direction of effect for other
SNPs is also summarised in ESM Table 3.
To investigate the possible existence of a secondary signal, we
performed a stepwise conditional analysis using the previously
reported European SNPs as covariates. Through these analyses,
we identified one additional SNP, rs11024184 (KCNQ1 ,
p =9.1×10−4 and p.condition1 =8.1×10−8; ESM Table 4
and ESM Fig. 3). We next evaluated the haplotype block struc-
ture ofKCNQ1 and found that these two SNPs (rs11024184 and
rs2237897) were not correlated (r2=0.07) and were on different
LD blocks, suggesting that this was an independent secondary
signal (ESM Fig. 4).
Type 2 diabetes and related-trait loci with putative novel lead
SNPs Of the 14 European type 2 diabetes loci that were also
significant in the Chinese population, the strongest p value
found in nine loci was for a putative novel lead SNP (Table 2).
The regional association plots of these loci also showed robust
signals in these regions (ESM Fig. 5).
To investigate whether these putative novel SNPs were
replication or secondary signals, we performed conditional
analysis using the European SNP as covariates similar to the
method described above. Of these nine lead SNPs, five
(rs2943632, IRS1 ; rs9356744, CDKAL1 ; rs11774700,
SLC30A8 [ESM Fig. 6]; rs2074314, KCNJ11/ABCC8 ;
rs8064454,HNF1B [TCF2 ]) became insignificant, indicating
they were replication SNPs (in LD with previously reported
European SNPs). Two SNPs failed QC and had no proxies on
theMetabochip; thus their independence could not be assessed.
Two SNPs (rs12378556, GLIS3 , p.condition1 =2.4×10−3 and
rs10882091, IDE/KIF11/HHEX , p.condition1 =4.9×10−3,
Fig. 1) remained significant, suggesting novel independent
signals (ESM Table 5).
Furthermore, using a stepwise conditional analysis in
which we conditioned on the top lead SNP in our dataset,
we identified four additional SNPs (rs2138157, IRS1, p.condi-
tion2=0.03; rs7773318, CDKAL1 , p.condition2 =3.0×10−4;
Table 2 Top 14 loci of type 2 diabetes from European individuals and the lead SNP observed in Chinese individuals
Locus Chr Lead SNP Putative novel
SNP
SNP category A1 A2 MAF OR p value (adjusted
for age, sex, PC1)
KCNQ1* 11 rs2237897 No Type 2 diabetes T C 0.34 0.80 5.7×10−12
CDKN2A/B-CDKN2BAS* 9 rs10811661 No Type 2 diabetes C T 0.41 0.85 5.0×10−8
CDC123/CAMK1D* 10 rs11257655 No Type 2 diabetes, fasting glucose C T 0.43 0.87 2.3×10−6
KCNJ11/ABCC8* 11 rs2074314 Yes Type 2 diabetes G A 0.37 1.15 3.5×10−6
IGF2BP2* 3 rs6769511 No Type 2 diabetes C T 0.26 1.17 5.0×10−6
HNF1B (TCF2) 17 rs8064454 Yes Type 2 diabetes A C 0.28 1.16 1.3×10−5
CDKAL1 6 rs9356744 Yes Type 2 diabetes C T 0.36 1.14 2.1×10−5
IDE/KIF11/HHEX 10 rs10882091 Yes Type 2 diabetes, fasting glucose C T 0.08 1.30 2.9×10−5
UBE2E2 3 rs17012800 Yes Type 2 diabetes G A 0.19 0.86 4.3×10−5
GCKR 2 rs1260326 No Type 2 diabetes, 2 h glucose,
fasting glucose
T C 0.49 0.89 9.6×10−5
IRS1-LOC646736 2 rs2943632 Yes Type 2 diabetes A G 0.08 0.82 1.8×10−4
SLC30A8 8 rs11774700 Yes Type 2 diabetes, 2 h glucose,
fasting glucose
C T 0.45 0.90 2.7×10−4
GLIS3 9 rs12378556 Yes Fasting glucose G A 0.38 1.11 4.0×10−4
PRC1 15 rs3743451 Yes Type 2 diabetes T C 0.48 0.90 8.9×10−4
*Loci that met LD pruned Bonferroni correction of 5.5×10−6
A1, minor allele; A2, major allele; Chr, chromosome; PC1, first PC
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rs9465994, CDKAL1 , p.condition2 =4.1×10−3; rs10974438,
GLIS3 , p.condition2 =0.03) that appeared to be independent
signals (ESM Table 5). Of interest, two of the four independent
signals were found at the 3’ end of the CDKAL1 gene.
In summary, a total of 10 SNPs replicated a previously
reported European signal. Though five were more significant
in the Asian population, they were in LD with previous
European signals. A total of seven novel independent secondary
signals were identified in this study (Table 3).
Novel locus at the 3′ end of CDKAL1 Using finemapping, our
data demonstrated that there were two peaks associated
with type 2 diabetes on the CDKAL1 gene (Fig. 2a). The first
peak lay at the 5′ end of the gene, closer to E2F3 , with a
significance of p =2.1×10−5 observed by the lead SNP
rs9356744. SNP rs9356744 was in tight LD with rs10440833
(proxy, rs9368222), which was previously reported in a large
European type 2 diabetes study of 42,542 cases and 98,912
controls [25]. Conditional analysis on rs9368222 diminished all
the signals at the 5′ end of CDKAL1 and negated the statistical
significance (Fig. 2b and ESM Table 5). On the other hand, it
did not affect the second peak, which lay at the 3′ end of
CDKAL1 (Fig. 2b).
Further stepwise conditional analysis thus identified two
independent signals at the 3′ end: SNPs rs7773318 and
rs9465994 (Fig. 2b, c; ESMTable 5). This result demonstrates
that the 3′ end of CDKAL1 is an independent locus observed
only in the Chinese population to date (Fig. 2b, c). This region
was also plotted using Asian and European LD patterns to
demonstrate an intrinsic LD difference between the two
ethnicities (ESM Fig. 7).
Discussion
We have demonstrated that a majority of loci associated with
type 2 diabetes discovered in European populations appear to
also serve as susceptibility loci for the same trait in the
Chinese population. Of the 50 loci tested, 14 of the loci met
our locus Bonferroni criteria and another 24 were nominally
significant. Furthermore, we identified a total of seven novel
ethnic-specific variants for type 2 diabetes in the Chinese
population using a fine-mapping approach. Of particular in-
terest, two independent SNPs lie at the 3′ end of the CDKAL1
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Fig. 1 Regional association plot of unconditional (a , c) and conditional
(b , d) analysis of GLIS3 (a , b) and IDE/KIF11/HHEX (c , d); examples
of retaining significance after performing a conditional analysis on a
previously reported European SNP. The lead East Asian SNP is
represented by a purple diamond. The European SNP is indicated by an
arrow, with the colour corresponding to the r2 of the two SNPs plotted in
the Asian LD pattern. Chr, chromosome
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loci, the 5′ end of which is seen in both Europeans and East
Asians and the 3′ end of which appears to be a novel inde-
pendent locus for type 2 diabetes in Chinese individuals.
Our most important finding may well be the identification
of two peaks on CDKAL1 . All previously reported SNPs of
CDKAL1 in type 2 diabetes (rs7756992 [26], rs7754840 [27,
28], rs4712523 [27, 29, 30], rs10946398 [31], rs9465871 [31,
32], rs4712524 [5], rs9295474 [11], and rs10440833 [25]) lie
within the 5′ end of the gene, and many of these SNPs are also
observed in Chinese individuals [11, 33, 34]. None of the
previously reported SNPs of CDKAL1 in type 2 diabetes lie
within the 3′ end of the gene. Our finding was possible because
CDKAL1 was one of the five selected loci to be fine-mapped
on the Metabochip [17].
CDKAL1 catalyses a methyl-thio group, which possibly
causes misfolding of proinsulin [35] and inhibits pancreatic
CDK5/p35 complex [26], thereby altering beta cell function
and insulin production. Earlier GWAS studies found variants
at the 5′ of CDKAL1 in individuals with impaired insulin
secretion but the functional variant has yet to be determined.
We therefore used an available database to discover whether
the two novel SNPs at the 3’ end of CDKAL1 (rs7773318 and
rs9465994) were eSNPs [24]. Though both rs7773318 and
rs9465994 are neither eSNPs nor in LD with previously
reported eSNPs (rs9460563, rs9460612, rs59633892,
rs62404554, and rs10946439) on CDKAL1 , we note
that eSNPs located at the 5′ end of CDKAL1 are mostly
Table 3 Summary of top SNPs, either as replication or secondary signals





GCKR 2 rs1260326 Replication Same as European
IRS1/
LOC646736
2 rs2943632 Replication More significant
in Asiansrs2138157 Secondary
UBE2E2 3 rs17012800 NA (no proxy)
IGF2BP2 3 rs6769511 Replication Same as European
CDKAL1 6 rs9356744 Replication More significant
in Asiansrs7773318 Secondary
rs9465994 Secondary
SLC30A8 8 rs11774700 Replication More significant
in Asians




9 rs10811661 Replication Same as European
CDC123/
CAMK1D








11 rs2074314 Replication More significant
in Asians
PRC1 15 rs3743451 NA (no proxy)
HNF1B (TCF2) 17 rs8064454 Replication More significant
in Asians
SNPs that are in LDwith a previous European SNP are replication signals
(i.e. not significant after conditional analysis). SNPs that not in LD with a
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Fig. 2 Regional association plot shows two peaks associated with type 2
diabetes at CDKAL1 : a 5′ peak that is closer to E2F3 and another peak
closer to the 3′ of CDKAL1 (a). Conditional analysis performed on
rs9368222, which is a proxy for rs9356744 and rs10440833, negated
the statistical significance at the 5′ peak but had no effect on the 3′ peak,
indicating a novel independent locus at the 3′ end of CDKAL1 for type 2
diabetes in the Chinese population and demonstrates that rs7773318 (b)
and rs9465994 (c) are novel ethnic-specific SNPs
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trans -acting regulators, while the eSNPs located at the
3’ end of CDKAL1 are all cis -acting. This observation sup-
ports the concept that SNPs in the 3’ end ofCDKAL1 regulate
the expression of this gene.
In this study, although we chose a locus-specific Bonferroni
correction (a less stringent statistical cut-off for association), we
also performed a more stringent statistical analysis for unlinked
markers. We found that five loci remained significant after
correction for multiple testing; however, only one locus
had a putative novel SNP in the East Asian population. This
locus was later found through conditional analysis to be
highly correlated with an SNP previously reported in a
European population.
Of the 50 tested loci, 14 loci were significant in the Chinese
population after locus Bonferroni correction. Collectively, a
total of 38 loci (76%, 38/50 loci) transferred to the Chinese
population with at least a nominal significance, highlighting a
great deal of genetic homogeneity for type 2 diabetes between
the European and Chinese populations.
In this study, 12 of the 50 loci were not observed to be
significant. In comparison with earlier studies involving
Chinese individuals, our result is similar (i.e. non-significant
in both this study and other Chinese cohorts) for NOTCH2
[33], SLC2A2 [36], WFS1 [33, 37], GCK [38] and HNF1A
[39, 40] but different (i.e. non-significant in this study but was
significant in other Chinese cohorts) for MTNR1B [41–43],
GCK [41, 42] and SREBF1 [44]. Comparisons could not be
made for KLF14 , TP53INP1 , CHCHD9/TLE4 , HMGA2 and
ZFAND6 as these genes were not tested in other Chinese
cohorts. Although our result was not significant forMTNR1B ,
GCK and SREBF1 , the direction of effect was concordant
with other Chinese [41, 42] and European [25, 45] studies for
both MTNR1B and GCK , but was unavailable (no proxy)
for SREBF1 .
Through conditional analysis, a total of seven potential
secondary signals were identified. To illustrate ethnic speci-
ficity, we give an example for SNP rs11024184 on KCNQ1 .
Using HapMap, the allele frequency of the A allele is seen in
9.2% of East Asians, but in as many as 53.3% of Europeans.
SNP rs11024184 lies 25 kb upstream of rs2237897 (the
previously reported European SNP) on KCNQ1 and the two
SNPs are neither in LD with each other nor on the same LD
block. Furthermore, rs11024184 does not tag any other SNP
in the region at r2>0.8. Collectively, these data suggest this is
an independent signal found in the Chinese population.
Comparing the Chinese and European populations, among
the other six potential secondary signals, the minor allele
frequency is similar for GLIS3 (rs12378556; rs10974438)
but different for IDE/KIF11/HHEX (rs10882091) and IRS1
(rs2138157). For CDKAL1 , the minor allele frequency is
similar for rs9465994 but different for rs7773318.
There are several strengths to this study. First, this is a
homogenous group of Chinese individuals, recruited at seven
principal sites in Taiwan, with well-defined phenotype and
ethnically matched controls. Second, to our knowledge, this is
the first Metabochip study using fine mapping of type 2
diabetes and related traits in East Asians. Third, and most
importantly, using this fine-mapping approach allows for the
redefining of the association signals at previously established
loci and the identification of a novel locus at the 3′ end of
CDKAL1 , which to date is only observed in the Chinese
population. There are also several limitations. The first is the
disparity of the regions covered on the Metabochip. Some
regions are more extensively fine-mapped than others, thus
there is a higher probability and opportunity to uncover inde-
pendent signals at these regions. Second, in the most recent
report from the MAGIC (Meta-Analyses of Glucose and
Insulin-related traits Consortium) and DIAGRAM (DIAbetes
Genetics Replication And Meta-analysis) consortia, a number
of additional type 2 diabetes loci have been identified in the
European population [46, 47].We examined, in this report, the
50 loci known to be associated with type 2 diabetes or its
related traits at the time of this investigation. Last, the
Metabochip is a pre-designed genotyping array of cardiovas-
cular and metabolic traits discovered in the European popula-
tion. Thus, the Metabochip is designed to test for SNPs and
loci only on the platform and is not designed to discover novel
SNPs and loci not previously related to cardiovascular or
metabolic traits in a genome-wide fashion.
In summary, we have identified a few ethnic-specific
variants and demonstrated a novel independent type 2
diabetes locus at the 3′ end of CDKAL1 in the Chinese
population. These findings provide initial clues to differences
in the genetic architecture underlying type 2 diabetes among
various ethnic populations.
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